Centenial Surgical Suture Board of Directors

Get the latest insights into the leadership at Centenial Surgical Suture. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Vijay Majrekar Managing Director & CEO
Ms. Anuradha Kashikar Executive Director & CFO
Mr. Devraj T Poojary Executive Director
Mr. Neel M Vora Ind. Non-Executive Director
Mr. Ridhima B Limaye Ind. Non-Executive Director
Mr. Akash S Modi Ind. Non-Executive Director
Mr. Anuj V Shah Ind. Non-Executive Director

Centenial Surgical Suture Share price

CSURGSU

117.1

7.30 (6.65%)
Last updated on 4 Sep, 2025 | 15:21 IST
BUYSELL
Today's High

120.00

Today's Low

102.40

52 Week Low

82.15

52 Week High

189.00

The current prices are delayed, login to your account for live prices

Centenial Surgical Suture FAQs

The board at Centenial Surgical Suture consists of experienced professionals, including Mr. Vijay Majrekar , Ms. Anuradha Kashikar , and others, overseeing the company’s strategic and corporate governance.

Directors at Centenial Surgical Suture are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Vijay Majrekar is the current chairman at Centenial Surgical Suture.

Executive directors at Centenial Surgical Suture are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Centenial Surgical Suture adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Centenial Surgical Suture, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.